Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1349studies shown
Showing 751-775 of 1,349
CompletedNCT04006548

To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics.

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

ADHDOtherFrom 6 Years to 17 Years
Countries
Taiwan
Sponsor
Chang Gung Memorial Hospital
Condition
ADHD
CompletedNCT04095377

Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

ADHDOtherOver 18 Years
Countries
Israel
Sponsor
QuantalX Neuroscience
Condition
ADHD
WithdrawnNCT04010851

The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD

This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

ADHDOtherFrom 6 Years to 12 Years
Countries
Global
Sponsor
Norwegian University of Science and Technology
Condition
ADHD
CompletedNCT00486551

Anger Control Training for Youth With Tourette Syndrome

This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 11 Years to 16 Years
Countries
United States
Sponsor
Yale University
Condition
ADHD
CompletedNCT04647903

Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Vallon Pharmaceuticals, Inc.
Condition
ADHD
CompletedNCT01907360

Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

ADHDOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Condition
ADHD
CompletedNCT02937142

Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 14 Years to 18 Years
Countries
Norway
Sponsor
St. Olavs Hospital
Condition
ADHD
TerminatedNCT03523663

System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 12 Years
Countries
United States
Sponsor
University of Wisconsin, Madison
Condition
ADHD
WithdrawnNCT01913912

Event Rate and Effects of Stimulants in ADHD

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 7 Years to 12 Years
Countries
Belgium
Sponsor
University Ghent
Condition
ADHD
CompletedNCT05138224

Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia

This study exists to learn from real-world information that can show how acceptance and commitment therapy, a talking treatment, fits into care. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 16 Years
Countries
Global
Sponsor
Great Ormond Street Hospital for Children NHS Foundation Trust
Condition
ADHD
CompletedNCT04018794

Development of a Mobile App for an Executive Functioning Intervention for Adolescents

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 11 Years to 15 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
ADHD
CompletedNCT02635035

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can better support energy, concentration, and everyday functioning.

ADHDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
ADHD
CompletedNCT02547428

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication Centanafadine offers something meaningfully different. Researchers are trying to understand how people respond to the medication Centanafadine in practice and what may need to be adjusted.

ADHDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
CompletedNCT04648553

Task-Based Grounding Program

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

ADHDOtherOver 9 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
ADHD
TerminatedNCT03942835

Psychometric Validation of the Competitive Attention Test

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 90 Years
Countries
France
Sponsor
Hospices Civils de Lyon
Condition
ADHD
CompletedNCT03324581

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

This study exists to understand whether the medication OPC-64005 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication OPC-64005 can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD